ストックスクリーナーアプリを入手
2.795
0.00%
0.005
前日終値:
$2.79
開ける：
$2.81
24時間の取引高:
799.91K
Relative Volume:
0.29
時価総額：
$562.25M
収益：
$216.56M
当期純損益:
$-9.57M
株価収益率:
-56.24
EPS:
-0.0497
ネットキャッシュフロー:
$-1.22M
1週間 パフォーマンス:
-6.38%
1か月 パフォーマンス:
-10.58%
6か月 パフォーマンス:
+15.77%
1年 パフォーマンス:
+132.50%
1日の値動き範囲:
$2.78
$2.87
1週間の範囲:
$2.76
$3.075
52週間の値動き範囲:
$1.17
$3.4698
Cerus Corp Stock (CERS) Company Profile
Compare CERS vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.79 | 574.35M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
116.42 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.36 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.15 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.73 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-12 | 開始されました | Craig Hallum | Buy |
| 2023-01-20 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-01-17 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | 再開されました | BTIG Research | Buy |
| 2020-06-16 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-02-26 | 開始されました | BTIG Research | Buy |
| 2019-11-13 | アップグレード | BTIG Research | Neutral → Buy |
| 2019-08-28 | 開始されました | Stifel | Buy |
| 2019-08-23 | 再開されました | Stephens | Overweight |
| 2018-01-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2017-12-08 | 再開されました | BTIG Research | Neutral |
| 2016-07-07 | 再開されました | Cantor Fitzgerald | Buy |
| 2015-12-17 | ダウングレード | Wedbush | Outperform → Neutral |
| 2014-05-02 | 繰り返されました | MLV & Co | Buy |
| 2013-04-24 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2013-03-15 | 繰り返されました | MLV & Co | Buy |
| 2012-04-17 | 開始されました | Cantor Fitzgerald | Buy |
| 2012-02-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | 繰り返されました | MLV & Co | Buy |
| 2011-06-03 | 開始されました | Wedbush | Outperform |
| 2011-03-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | アップグレード | Avondale | Mkt Perform → Mkt Outperform |
すべてを表示
Cerus Corp (CERS) 最新ニュース
CERS Initiates Coverage On Freedom Broker -- Price Target Announ - GuruFocus
Cerus: This Blood-Safety Underdog Should Be Earning More Respect (NASDAQ:CERS) - Seeking Alpha
Cerus Corp (CERS) Chief Legal Officer Chrystal Jensen Sells 30,0 - GuruFocus
Cerus Corp chief legal officer sells $89,529 in company stock. - Investing.com
Cerus Corp chief legal officer sells $89,529 in company stock. By Investing.com - Investing.com India
Cerus (CERS) legal chief sells 30,000 shares in preset plan - Stock Titan
Cerus (NASDAQ: CERS) insider moves to sell more stock after July sale - Stock Titan
Assenagon Asset Management S.A. Has $920,000 Stock Holdings in Cerus Corporation $CERS - MarketBeat
Cerus (NASDAQ:CERS) Downgraded by Wall Street Zen to Hold - MarketBeat
Baker Bros. cuts Cerus Corporation (CERS) position to 3.2% ownership stake - Stock Titan
Cerus Corp (CERS): ARK Investment, Catherine Wood report 8.95% ownership stake - Stock Titan
Cerus Corp (CERS) sees Soleus Capital group report 1.2% beneficial stake - Stock Titan
Wasatch Advisors LP Sells 1,897,237 Shares of Cerus Corporation $CERS - MarketBeat
Cerus Corp (CERS) Stock News Today - TradingKey
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cerus (CERS) Institutional Ownership 2026 $CERS - MarketBeat
Cerus Corporation Q2 2026 10-Q Report: Financial Statements, Risk Factors, and SEC Filings Overview - Minichart
CERS Looks 26.3% Overvalued on GF Value™ - GuruFocus
Cerus Q2 revenue rises to $63.3 million - Quiver Quantitative
Cerus reports Q2 2026 revenue $63.3M; product revenue $57.4M, raises 2026 product guidance - TradingView
Cerus: Q2 Earnings Snapshot - KING5.com
Cerus raises FY26 sales guidance to $229-231M as Q2 EPS meets estimates - scanx.trade
Cerus Corp expected to post a loss of 1 cent a shareEarnings Preview - TradingView
CERS|Cerus Corp|Price:3.065|Chg%:+0.135 - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Cash Flow - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cerus Corp (CERS) Income Statement - TradingKey
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERS|Cerus Corp|Price:2.845|Chg%:+0.135 - TradingKey
Cerus (CERS) to Announce Quarterly Earnings on Thursday - MarketBeat
AlTi Global Leads Our Selection Of 3 Promising Penny Stocks - simplywall.st
Cerus Corp (CERS) CEO trades 16666 shares under 10b5-1 plan - Stock Titan
Cerus Corporation (CERS) Edges Higher as Stock Holds Above Key SupportDiagonal Spread Trade - dars.gov.et
Cerus Corporation (NASDAQ:CERS) Short Interest Down 35.3% in June - MarketBeat
CERS: Cerus Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Press Release: Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026 - Moomoo
Cerus Corporation to release Q2 2026 results on July 30 - scanx.trade
CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026 - Stock Titan
Cerus to Discuss Results and Outlook in July 30 Webcast - Stock Titan
Cerus Corporation Announces Executive Chairman Transition and Employment Agreement Amendment – SEC 8-K Filing July 2026 - Minichart
Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman - Stock Titan
Cerus Corp faces a complex landscape as blood safety technology evolves - Ad-hoc-news.de
ETFs Investing in Cerus Corporation Stocks - TradingView
Cerus Corp updates focus on blood safety. Business model supports long-term growth - Ad-hoc-news.de
Cerus Corp looks to blood safety technology as investors weigh long-term growth - ad-hoc-news.de
Cerus Company Profile & Introduction - Moomoo
CERSCerus Corp Latest SEC Filings - Finviz
CERS Should I Buy - Intellectia AI
Cerus Corp (CERS) 財務データ
収益
当期純利益
現金流量
EPS
1.36%
大文字化:
|
ボリューム (24 時間):